Top Markets
Coin of the day
IR Biosciences Holdings Inc. IR Biosciences Holdings Inc.

IR Biosciences Holdings Inc.

IRBS
Rank in Stocks #40519
IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm.... IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for significant health challenges, including pulmonary fibrosis, influenza infections, and neutropenia caused by radiation. The company is also actively developing Homspera and its derivatives, Radilex and Viprovex. These compounds are designed to stimulate human stem cells, enhance immune system responses, offer anti-infective properties, serve as vaccine adjuvants, and promote wound healing. Founded in 1999, IR BioSciences Holdings, Inc. maintains its headquarters in Scottsdale, Arizona.
Share Price
$0.00006
Last synced: 2025-07-15
Market Cap
$128.12K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade IR Biosciences Holdings Inc. (IRBS)

Category

P/B ratio for IR Biosciences Holdings Inc. (IRBS)
P/B ratio as of 2026 TTM: 0
According to IR Biosciences Holdings Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for IR Biosciences Holdings Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE